GNH USA

Europe — EMA

Nimesulida Ratiopharm (Nimesulide)

GNH USA supplies Nimesulida Ratiopharm (Nimesulide), a nonsteroidal anti-inflammatory drug for mild to moderate pain, osteoarthritis and dysmenorrhea.

Nimesulide

Request sourcing

1
Pack/s

What is Nimesulide?

Nimesulide, the active ingredient in Nimesulida Ratiopharm, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It is indicated for mild to moderate pain, inflammatory joint conditions and dysmenorrhea in adult patients.

GNH USA supplies Nimesulida Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Nimesulide used for?

Nimesulida Ratiopharm is an NSAID that reduces inflammation and pain in several common conditions. - Mild to moderate pain: provides analgesic relief by decreasing prostaglandin‑mediated nociception. - Osteoarthritis: alleviates joint discomfort and improves mobility through anti‑inflammatory action. - Dysmenorrhea: reduces menstrual cramps by inhibiting uterine prostaglandin synthesis.

What are the side effects of Nimesulide?

Adverse reactions may occur with any NSAID and vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching. - Elevated liver enzymes detected in routine labs.

Serious or Rare Side Effects: - Hepatotoxicity: jaundice, hepatitis, or severe liver injury. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal impairment: acute kidney injury or reduced renal function. - Cardiovascular events: increased risk of thrombotic events. - Anaphylaxis: rare but potentially life‑threatening allergic reaction.

What precautions apply to Nimesulide?

Before prescribing Nimesulida Ratiopharm, clinicians should consider several safety aspects. - Liver function: assess baseline hepatic enzymes and monitor periodically. - Renal function: evaluate kidney status, especially in patients with pre‑existing impairment. - Gastrointestinal risk: avoid in individuals with active ulcers or a history of serious GI bleeding. - Cardiovascular disease: use cautiously in patients with hypertension or coronary artery disease. - Pregnancy and lactation: contraindicated unless clearly justified by a physician. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

What does Nimesulide interact with?

Nimesulida Ratiopharm may alter the effect of other medicines; careful review is required.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal and renal toxicity. - Hepatotoxic drugs (e.g., isoniazid, methotrexate): heightened liver injury potential.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive effect. - Diuretics: risk of reduced renal perfusion. - Lithium: NSAIDs may raise serum lithium levels. - Corticosteroids: enhanced risk of GI ulceration.

Frequently asked questions

What conditions is Nimesulida Ratiopharm used for?+
Nimesulida Ratiopharm is prescribed to relieve mild to moderate pain, reduce inflammation in osteoarthritis, and treat dysmenorrhea. It works by targeting the inflammatory pathway that contributes to these symptoms, providing symptomatic relief for adult patients.
How does nimesulide work in the body?+
Nimesulide selectively blocks the cyclooxygenase‑2 (COX‑2) enzyme, which limits the production of prostaglandins that mediate inflammation, pain, and fever. By reducing prostaglandin synthesis, it diminishes the inflammatory response while sparing COX‑1 activity that protects the stomach lining.
What is the usual dose of Nimesulida Ratiopharm?+
The exact dosage of Nimesulida Ratiopharm is determined by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Nimesulida Ratiopharm safe during pregnancy or breastfeeding?+
Nimesulida Ratiopharm is generally avoided during pregnancy and lactation unless the potential benefit outweighs the risk and a physician explicitly recommends it. Safety data are limited, so clinicians usually select alternative therapies for pregnant or nursing women.
How do I order Nimesulida Ratiopharm from GNH USA?+
To request Nimesulida Ratiopharm, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Nimesulida Ratiopharm compare with other NSAIDs?+
Compared with non‑selective NSAIDs, nimesulide offers relatively greater COX‑2 selectivity, which may reduce the risk of gastric irritation. However, it still carries potential hepatic and renal risks, and its safety profile must be weighed against alternatives such as ibuprofen or diclofenac on a case‑by‑case basis.
What are the storage requirements for Nimesulida Ratiopharm?+
Nimesulida Ratiopharm should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.
How is Nimesulida Ratiopharm administered?+
The medication is taken orally, usually with a full glass of water. It can be taken with or without food, but patients who experience stomach upset may benefit from taking it with meals. The exact timing and frequency are set by the prescribing healthcare professional.
What are the most serious risks associated with Nimesulida Ratiopharm?+
Serious adverse events include hepatotoxicity, severe skin reactions such as Stevens‑Johnson syndrome, and rare but significant cardiovascular events. Patients should be monitored for signs of liver dysfunction, rash, or unusual bleeding, and seek immediate medical attention if these occur.
Who should not use Nimesulida Ratiopharm?+
Individuals with known hypersensitivity to nimesulide or other NSAIDs, active peptic ulcer disease, severe liver or kidney impairment, and those in the third trimester of pregnancy should avoid Nimesulida Ratiopharm. A physician should evaluate any other contraindications before prescribing.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Nimesulide
Route
Oral Use
Manufacturer
Ratiopharm-Comercio E Industria De Produtos Farmaceuticos Lda
Origin
EU

Related products

Actalide

Actalide

Nimesulide

Errekappa Euroterapici Spa
EU
Actalide

Actalide

Nimesulide

Errekappa Euroterapici Spa
EU
Algolider

Algolider

Nimesulide

Siar Pharma S.R.L.
EU
Aponil

Aponil

Nimesulide

Medochemie Ltd.
EU